1
NSG 6001 QUIZ 7 LATEST 2026/2027 | PRIMARY
CARE ADULT-GERONTOLOGY | 50 VERIFIED
Q&A | DETAILED RATIONALES | NGN-ALIGNED |
PASS GUARANTEED – A+ GRADED
SECTION I: CARDIOVASCULAR DISORDERS – Questions 1-6
Q1: Hypertension – Nocturnal Hypertension
The student is reviewing hypertension. A patient has normal daytime blood pressure but elevated
nighttime readings on ambulatory monitoring. What is this condition called?
A. White coat hypertension
B. Masked hypertension
C. Nocturnal hypertension
D. Resistant hypertension
Correct Answer: C
Rationale: Nocturnal hypertension is elevated blood pressure during sleep, often defined as
nighttime BP ≥120/70 mm Hg. It is associated with increased cardiovascular risk and is commonly
seen in obstructive sleep apnea, chronic kidney disease, and diabetes. [100% CORRECT]
Q2: Heart Failure – CardioMEMS
The student is reviewing heart failure. What is the CardioMEMS device?
A. An implantable pulmonary artery pressure monitor
B. A cardiac pacemaker
C. An implantable defibrillator
D. A left ventricular assist device
Correct Answer: A
Rationale: CardioMEMS is an implantable wireless pulmonary artery pressure monitor that allows
remote monitoring of filling pressures in HFrEF. It reduces hospitalizations when used to guide
therapy. [100% CORRECT]
Q3: Atrial Fibrillation – WATCHMAN Device
The student is reviewing atrial fibrillation. What is the WATCHMAN device?
A. A left atrial appendage closure device to prevent stroke
B. A pacemaker
C. An implantable cardioverter-defibrillator
D. A cardiac resynchronization device
, 2
Correct Answer: A
Rationale: The WATCHMAN device is a left atrial appendage closure device implanted
percutaneously to reduce stroke risk in patients with AF who cannot tolerate long-term
anticoagulation. [100% CORRECT]
Q4: Hyperlipidemia – Inclisiran
The student is reviewing lipid management. What is inclisiran?
A. A siRNA that lowers LDL by inhibiting PCSK9 synthesis
B. A statin
C. A PCSK9 inhibitor antibody
D. A fibrate
Correct Answer: A
Rationale: Inclisiran is a small interfering RNA (siRNA) that inhibits PCSK9 synthesis, lowering LDL
cholesterol. It is given subcutaneously every 6 months. [100% CORRECT]
Q5: Acute Coronary Syndrome – TIMI Risk Score
The student is reviewing ACS. What does the TIMI risk score predict?
A. 14-day risk of death, MI, or urgent revascularization in ACS
B. Bleeding risk
C. Stroke risk
D. Heart failure risk
Correct Answer: A
Rationale: The TIMI risk score predicts the 14-day risk of death, myocardial infarction, or urgent
revascularization in patients with unstable angina/NSTEMI. It includes age ≥65, ≥3 CAD risk factors,
known CAD, ASA use, severe angina, ST deviation, and elevated troponin. [100% CORRECT]
Q6: Peripheral Artery Disease – Paclitaxel-Coated Balloons
The student is reviewing PAD. What is a concern with paclitaxel-coated balloons?
A. Increased late mortality
B. Increased restenosis
C. Increased bleeding
D. Increased infection
Correct Answer: A
Rationale: Paclitaxel-coated balloons and stents for femoropopliteal PAD have been associated with
a signal of increased late mortality in some meta-analyses. This has led to cautious use and ongoing
investigation. [100% CORRECT]
SECTION II: RESPIRATORY DISORDERS – Questions 7-12
NSG 6001 QUIZ 7 LATEST 2026/2027 | PRIMARY
CARE ADULT-GERONTOLOGY | 50 VERIFIED
Q&A | DETAILED RATIONALES | NGN-ALIGNED |
PASS GUARANTEED – A+ GRADED
SECTION I: CARDIOVASCULAR DISORDERS – Questions 1-6
Q1: Hypertension – Nocturnal Hypertension
The student is reviewing hypertension. A patient has normal daytime blood pressure but elevated
nighttime readings on ambulatory monitoring. What is this condition called?
A. White coat hypertension
B. Masked hypertension
C. Nocturnal hypertension
D. Resistant hypertension
Correct Answer: C
Rationale: Nocturnal hypertension is elevated blood pressure during sleep, often defined as
nighttime BP ≥120/70 mm Hg. It is associated with increased cardiovascular risk and is commonly
seen in obstructive sleep apnea, chronic kidney disease, and diabetes. [100% CORRECT]
Q2: Heart Failure – CardioMEMS
The student is reviewing heart failure. What is the CardioMEMS device?
A. An implantable pulmonary artery pressure monitor
B. A cardiac pacemaker
C. An implantable defibrillator
D. A left ventricular assist device
Correct Answer: A
Rationale: CardioMEMS is an implantable wireless pulmonary artery pressure monitor that allows
remote monitoring of filling pressures in HFrEF. It reduces hospitalizations when used to guide
therapy. [100% CORRECT]
Q3: Atrial Fibrillation – WATCHMAN Device
The student is reviewing atrial fibrillation. What is the WATCHMAN device?
A. A left atrial appendage closure device to prevent stroke
B. A pacemaker
C. An implantable cardioverter-defibrillator
D. A cardiac resynchronization device
, 2
Correct Answer: A
Rationale: The WATCHMAN device is a left atrial appendage closure device implanted
percutaneously to reduce stroke risk in patients with AF who cannot tolerate long-term
anticoagulation. [100% CORRECT]
Q4: Hyperlipidemia – Inclisiran
The student is reviewing lipid management. What is inclisiran?
A. A siRNA that lowers LDL by inhibiting PCSK9 synthesis
B. A statin
C. A PCSK9 inhibitor antibody
D. A fibrate
Correct Answer: A
Rationale: Inclisiran is a small interfering RNA (siRNA) that inhibits PCSK9 synthesis, lowering LDL
cholesterol. It is given subcutaneously every 6 months. [100% CORRECT]
Q5: Acute Coronary Syndrome – TIMI Risk Score
The student is reviewing ACS. What does the TIMI risk score predict?
A. 14-day risk of death, MI, or urgent revascularization in ACS
B. Bleeding risk
C. Stroke risk
D. Heart failure risk
Correct Answer: A
Rationale: The TIMI risk score predicts the 14-day risk of death, myocardial infarction, or urgent
revascularization in patients with unstable angina/NSTEMI. It includes age ≥65, ≥3 CAD risk factors,
known CAD, ASA use, severe angina, ST deviation, and elevated troponin. [100% CORRECT]
Q6: Peripheral Artery Disease – Paclitaxel-Coated Balloons
The student is reviewing PAD. What is a concern with paclitaxel-coated balloons?
A. Increased late mortality
B. Increased restenosis
C. Increased bleeding
D. Increased infection
Correct Answer: A
Rationale: Paclitaxel-coated balloons and stents for femoropopliteal PAD have been associated with
a signal of increased late mortality in some meta-analyses. This has led to cautious use and ongoing
investigation. [100% CORRECT]
SECTION II: RESPIRATORY DISORDERS – Questions 7-12
